Renal Anemia Treatment Market
Published date: May 2023 • Report Code: 14265
Request Sample Order This Report
Renal Anemia Treatment Market

Global Renal Anemia Treatment Market Size, Growth Rate, Drivers, Threats, Applications, Trends, and Forecast to 2028

  • 14265

  • May 2023

  • 164

  • Format PDF Format XLS Format PPT

    • ★★★★★
      ★★★★★
    • (16)

  • Healthcare

This report was compiled by Correspondence Linkedin | Detailed Market research Methodology Our methodology involves a mix of primary research, including interviews with leading mental health experts, and secondary research from reputable medical journals and databases. View Detailed Methodology Page

  •  “Global Renal Anemia Treatment Market” is an upcoming report created by market analysts at MarketResearch.biz. The target market is expected to be valued at US$ X.X Mn in 2019 and is projected to witness lucrative CAGR over the 10-year period. The global market report has been segmented on the basis of medicine type, route of administration, distribution channel, and region/ country.

    Renal Anemia Treatment: Overview

    Renal Anemia is a chronic condition caused due to low count of red blood cells (RBC) or minimal oxygen carried by RBC to organs and tissues, specifically brain and heart. On the basis of etiology, anemia is categorized into three types such as blood loss, low RBC production, and high RBC destruction. Patients suffering from chronic kidney disease (CKD), commonly get anemia. When kidneys do not function appropriately or are damaged, they are unable to produce required amount of erythropoietin hormone, which plays vital role in production of red blood cells. This can result in less production of RBC by bone marrow, causing anemia. Some of the common causes include low iron level, folic acid, and vitamin B12; chronic infections, issues related to bone marrow, and malnutrition. Renal anemia is mostly diagnosed by examining medical history and blood tests among other options.

    Dynamics: Market Growth Drivers, Trends and Threats

    Increasing number of patients with CKD, rising number of kidney transplants among people due to permanent or partial loss of kidney functions are major factors expected to drive growth of the global market.

    Increasing prevalence of kidney diseases wherein they get damaged due to blood loss from hemodialysis or due to less consumption of nutritional content such as iron, vitamin B12, and folic acid is another major factor expected to drive growth of the global market. Increasing investments by certain major companies on R&D of enhanced drugs and launch of medicines to overcome anemia is expected to drive market growth. For instance, Novartis launched its new product – Binocrit –  for renal anemia treatment associated with chronic renal failure.

    However, high cost of drugs and potential side-effects such as chronic blood pressure issues and thromboembolic complications are major factors that could hamper growth of the target market. Moreover, consumption of erythropoiesis-stimulating agents by cancer patients can augment growth of tumor, which is another factor that could challenge market growth.

    Segment Analysis

    By Medicine Type:

    Among the type segments, the erythrocyte stimulating agents and iron supplements segments are expected to contribute higher shares in terms of revenue.

    By Route of Administration:

    Among the route of administration segments, the parenteral segment is estimated to account for major share in terms of revenue and adoption rate, as healthcare professionals prefer injectable route of administration of medicines for renal anemia.

    By Distribution Channel:

    Among the segments based on distribution channel, the retail pharmacy segment is anticipated to account for moderate share in terms of revenue owing to easy and faster accessibility to 24-hour pharmacies. The online pharmacy segment is anticipated to grow at a significant CAGR owing to rising preference for purchasing medicines online at discounted prices.

    Regional Analysis

    The North America market accounted for the largest share in terms of revenue in the global market, owing to presence of major players, coupled with rising investments in R&D activities for development of new, enhanced, and innovative drugs. In addition, rising prevalence of chronic kidney diseases due to unhealthy eating and drinking habits is another factor expected to support growth of the NA market. The APAC renal anemia treatment market is projected to register the highest growth rate owing to rapidly flourishing healthcare sector, rising medical tourism, and rising number of patients suffering from anemia, and need for treatment of kidney-related diseases. The MEA and Latin America markets are expected to grow at a moderate growth rate in the next 10 years.

    Global Renal Anemia Treatment Market Segmentation:

    Segmentation by Medicine Type:

    • Iron Supplements
    • Erythrocyte Stimulating Agents
    • Red Blood Cell Transfusions
    • Vitamin B 12 and Folic Acid Supplements

    Segmentation by Route of Administration:

    • Oral
    • Parenteral

    Segmentation by Distribution Channel:

    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy 

    Segmentation by Region:

    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

    Attribute Report Details
    Market Size Ask For Market Size
    Growth Rate Ask For Growth Rate
    Key Companies Ask For Companies
    Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more…
    Historical Data Period 2015-2020
    Base Year 2022
    Forecast Period 2022-2031
    Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa
    Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa
    Revenue in US$ Mn

  • Request A Table Of Content

    Fill the form below to request a Table Of Content.


    • Amgen Inc.
    • Vifor Pharma Management Ltd.
    • Hoffmann-La Roche Ltd
    • Pfizer Inc.
    • Sandoz International GmbH (Novartis AG)
    • Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
    • Teva Pharmaceutical Industries Ltd.
    • AMAG Pharmaceuticals
    • Rockwell Medical
    • Akebia Therapeutics
✖
Request a Sample Report
We'll get back to you as quickly as possible

Wnat a quick look at the report?
Request Sample
Do you have a query?
Speak with analyst
Need personalized modifications?
Customize Report

Our Clients

  • Our Clients
    Our Clients

View Our Licence Options

Order This Report
Report Methodology Research Methodology
LOOKING FOR A PERSONALIZED REPORT?
Our team specializes in tailoring reports to your specific needs, and the best part? It's absolutely free. Whether you require standalone sections, country-level analysis, or discounts tailored for start-ups and universities, we've got you covered.
Request for Customization

MARKET RESEARCH REPORTS

MarketResearch.biz (Powered by Prudour Pvt. Ltd.) delivers customized research solutions by actuating its broad spectrum of research methodologies, databases, and resources, and this is further strengthened by our global experience in syndicated and customized industry projects.

Our tailor-made research services include quick market scans, country reports, in-depth market analysis, competition monitoring, consumer research and satisfaction studies, supplier research, growth planning, and quite a lot more.

SHORT NAVIGATION

CONTACT US